Zobrazeno 1 - 1
of 1
pro vyhledávání: '"drug therapy/pathology, Epirubicin"'
Autor:
PIERFRANCO CONTE, Michelotti, A., Baldini, E., Tibaldi, C., Daprato, M., Salvadori, B., Giannessi, P. G., Gentile, A., Biadi, O., Mariani, M.
Publikováno v:
Scopus-Elsevier
We performed a dose-escalation study to evaluate the maximum tolerated dose (MTD) of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) plus a fixed dose of epirubicin. Epirubicin was administered as a 90 mg/m2 bolus immediately followed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::93fa8fac455d34afeca309e90b939754
https://pubmed.ncbi.nlm.nih.gov/8629033
https://pubmed.ncbi.nlm.nih.gov/8629033
